+1.9%
AMKR vs MRNA
+945.0%
-943.1%
-61.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.2% | +13.1% | -18.3% | -5.2% |
| 7D | -15.5% | +20.6% | -36.2% | -15.5% |
| 30D | -34.7% | +27.1% | -61.9% | -34.6% |
| 3M | -36.1% | +353.4% | -389.4% | -36.5% |
| 6M | -49.6% | +446.3% | -495.9% | -54.3% |
| YTD | -9.2% | +776.2% | -785.4% | -29.8% |
| 1Y | +1.9% | +987.9% | -986.0% | -27.3% |
| All | +1.9% | +945.0% | -943.1% | -27.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling